-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $115

Benzinga·11/05/2026 19:03:17
Listen to the news
RBC Capital analyst Kendall Au maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $110 to $115.